Research project: Why adults use omega-3 fatty acids from themselves and their growing children
The Research and Innovation Platform at MBCI is about to launch its first online survey to examine…
The Research and Innovation Platform at MBCI is about to launch its first online survey to examine…
This study is an assessment of the overall performance of participants with symptomatic mild knee OA taking Tregocel®
A randomized controlled trial will be conducted by our research partners at Mahidol University to study the effects of…
A randomised, double-blind, 3 arm study will be conducted by Mahidol University in Thailand to evaluate the effect of a placebo verse a low or high dose of DASBRIAN omega-3 on neurocognitive performance in school children.
In a collaborative research study between the Max Biocare Institute and Mahidol University in Thailand, doctors and researchers are conducting a randomised controlled trial to…
In 2017, a collaborative clinical study between the Research and Innovation Platform at the MBCI and the National Hospital of Traditional Medicine in Vietnam, investigated the safety, efficacy and tolerability of GoutFighterTM for the treatment of gout induced pain, inflammation and hyperuricemia.
The Max Biocare Institute has partnered with Western Sydney University’s National Institute of Complementary Medicine (NICM) to conduct an open label trial, to study the clinical effectiveness of Hominax on improving sperm health in men diagnosed with mild to moderate infertility.
In 2010, the Max Biocare Institute collaborated with Hanoi Medical University in Vietnam on a clinical trial of PMH-Regulator® for the treatment of pre-menopausal and menopausal symptoms.